US · LMRI
Lumexa Imaging Holdings, Inc. Common Stock
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Raleigh, NC 27609
- Website
- lumexaimaging.com
Price · as of 2024-12-31
$10.00
Market cap 1.34B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | — | — |
| Intrinsic Value(DCF) | — | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Lumexa Imaging Holdings, Inc. Common Stock's (LMRI) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- —
- Current price
- $10.00
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
—
— upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| LMRI | Lumexa Imaging Holdings, … | $10.00 | 1.34B | — | — | — | — | — | — | — | — | — | — | 10.15% | 5.82% | -9.92% | -52.27% | 3.77% | -5.56% | 8.10 | 0.41 | 0.99 | 0.93 | 11.26 | -2248.00% | 138.00% | -409.00% | — | 0.23 | 0.88% | — | 0.00% | — | — | — | — | — |
| BSX | Boston Scientific Corpora… | $76.85 | 114.04B | -12% | -35% | -82% | -31% | 39.02 | 4.66 | 5.62 | 33.01 | 70.68 | -105.55 | 69.01% | 19.78% | 14.38% | 12.57% | 10.11% | 6.96% | 0.51 | 11.38 | 1.62 | 0.91 | 2.78 | 5520.00% | 1987.00% | 3830.00% | 3.24% | 0.83 | 10.90% | 0.00% | 0.00% | 0.32% | 31.03 | 33.68 | 6.14 | 4.56 |
| BWAY | BrainsWay Ltd. | $23.14 | 453.81M | +186% | +74% | -80% | -73% | 54.72 | 2.56 | 3.90 | 17.94 | — | 2.56 | 74.56% | 3.39% | 7.12% | 5.62% | -43.99% | 3.71% | 0.09 | 1.03 | 5.19 | 4.82 | -11.89 | -16923.00% | 2904.00% | -68966.00% | 4.07% | 0.67 | -243.55% | 0.00% | 0.00% | 33.58% | 69.09 | 14.78 | 2.34 | 2.84 |
| CODX | Co-Diagnostics, Inc. | $2.30 | 2.57M | +1,244% | +270% | — | +1,660% | -13.54 | 9.38 | 130.17 | -12.45 | -406.20 | 18.07 | 74.48% | -1023.75% | -961.37% | -53.65% | -140.21% | -47.25% | 0.04 | — | 4.41 | 4.08 | 0.02 | 333.00% | -4253.00% | 2754.00% | -5.87% | -3.99 | -104.61% | 0.00% | 0.00% | 0.00% | -12.03 | -16.12 | 123.12 | 29.30 |
| INSP | Inspire Medical Systems, … | $64.51 | 1.87B | +102% | +157% | -20% | +62% | 13.09 | 2.44 | 2.09 | 25.07 | 7.29 | 2.44 | 85.39% | 5.59% | 15.95% | 19.77% | 13.05% | 16.95% | 0.04 | 371.93 | 6.08 | 4.46 | -1.12 | 17943.00% | 1360.00% | -1388.00% | 4.12% | 1.22 | 20.10% | 0.00% | 0.00% | 9.20% | 31.94 | 20.74 | 1.78 | 10.66 |
| IRTC | iRhythm Technologies, Inc… | $133.75 | 4.32B | -14% | +116% | — | — | -92.28 | 26.92 | 5.50 | -1074.06 | — | 27.07 | 70.57% | -4.93% | -5.96% | -36.57% | -12.43% | -4.57% | 4.79 | -2.80 | 4.63 | 4.34 | -124.89 | -6171.00% | 2624.00% | -21299.00% | 0.84% | 0.53 | 11.65% | 0.00% | 0.00% | 0.00% | -115.69 | 123.36 | 5.70 | 3.00 |
| PRCT | PROCEPT BioRobotics Corpo… | $22.69 | 1.27B | +83% | +106% | — | — | -15.10 | 3.94 | 4.69 | -15.09 | — | 3.95 | 63.70% | -33.71% | -31.02% | -24.89% | -74.26% | -18.34% | 0.14 | -11.69 | 6.85 | 5.62 | 2.93 | -171.00% | 3722.00% | -4370.00% | -4.04% | -0.74 | -41.71% | 0.00% | 0.00% | 0.44% | -11.64 | -20.71 | 3.92 | 5.16 |
| SMLR | Semler Scientific, Inc. | $20.33 | 310.75M | +321% | +54% | +196% | — | 6.57 | 1.17 | 4.78 | 11.81 | 6.92 | 16.68 | 91.55% | 37.19% | 72.65% | 27.04% | 15.50% | 25.73% | 0.00 | — | 3.59 | 3.06 | -0.41 | 9506.00% | -1744.00% | 1881.00% | 9.06% | 3.87 | 21.12% | 0.00% | 0.00% | 0.00% | 12.13 | 10.43 | 4.51 | 18.96 |
| XAIR | Beyond Air, Inc. | $0.96 | 4.87M | +6,086% | +58% | — | — | -0.27 | 0.95 | 3.47 | -0.42 | — | 1.04 | -44.89% | -1202.08% | -1258.43% | -250.98% | -332.73% | -111.42% | 0.86 | -14.75 | 3.20 | 1.56 | -0.17 | -6210.00% | 21967.00% | -2859.00% | -342.82% | -7.64 | -329.47% | 0.00% | 0.00% | 0.00% | -0.40 | -0.40 | 4.76 | -17.17 |
About Lumexa Imaging Holdings, Inc. Common Stock
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. The company was founded in 2018 and is based in Raleigh, North Carolina.
- CEO
- Caitlin Zulla
- Employees
- 0
- Beta
- 0.00
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $10.00) − 1 = — (DCF, example).